Medical and PharmaceuticalPsychedelicsScience and ResearchPsilocybin treats depression as well as common antidepressant: study Jared GnamApril 15, 202112 min
CanadaCultureMedical and PharmaceuticalPsychedelicsSchedule I tea at the Coca Leaf Café Natalia Buendia CalvilloApril 7, 202118 min
Medical and PharmaceuticalPsychedelicsScience and ResearchLSD could be used to treat people with autism, study suggests Natalia Buendia CalvilloMarch 1, 20218 min
Medical and PharmaceuticalPsychedelicsScience and ResearchNature amplifies therapeutic effects of psychedelics: study Natalia Buendia CalvilloFebruary 23, 202114 min
AnalysisMedical and PharmaceuticalPsychedelicsField Trip white paper makes strong health and business case for ketamine therapy Natalia Buendia CalvilloFebruary 9, 202118 min
CanadaMedical and PharmaceuticalPsychedelicsRegulationsProposed amendment could greatly expand access to psychedelic therapy in Canada Natalia Buendia CalvilloJanuary 28, 202110 min
PsychedelicsRegulationsScience and Research2020’s top 5 advancements in psychedelics Jared GnamDecember 30, 202021 min
AnalysisCanadaPsychedelicsRegulationsWhat happened to Canada’s ibogaine clinics? Suzannah WeissDecember 23, 202014 min
Health and SafetyInternationalMedical and PharmaceuticalPsychedelicsWhat Measure 109 means for the future of psychedelic therapy Amna ShamimDecember 15, 202015 min
Investment IdeasPsychedelicsScience and ResearchMagicMed aims to mainstream psychedelic therapy with world’s largest ‘Psybrary’ Jared GnamDecember 1, 202015 min
